Bersabe, Irene S.

HRN: 21-69-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
CO-AMOXICLAV 625MG (TAB)
11/30/2022
12/07/2022
ORAL
625mg/tab
BID
S/P NSVD; THICKLY MSAF
Waiting Final Action 
12/01/2022
CEFUROXIME 500MG (TAB)
12/01/2022
12/08/2022
ORAL
500mg
Q12
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: